This bill could make drug companies owe larger Medicare rebates when their prices rise faster than inflation. It counts more drug sales in the formula and measures price growth from 2016 instead of 2021. The bill starts the new Part D rules in late 2025 and the new Part B rules in 2026.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Lower Drug Costs for Families Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Latest action on H.R. 2554: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Who this affects: This bill mainly affects drug companies first, because it changes how much they may owe when prices rise faster than inflation. Medicare also has a direct stake because it collects these rebates. Private insurers and employers could be affected indirectly, since commercial-market sales would count in some formulas even though the bill does not directly regulate private coverage. State Medicaid programs and 340B safety-net providers matter too because the bill excludes some of their drug units from certain counts.
Why this matters: This bill matters because it could make drug companies pay more when they raise prices faster than inflation, and that could change pricing behavior over time. By counting more units and using 2016 instead of 2021 as the baseline, the bill could raise rebate amounts for some drugs. That may lower federal drug spending or reduce pressure on Medicare costs, but the bill does not say whether patients would directly see lower out-of-pocket costs. It also tries to avoid double counting sales already tied to Medicaid rebates or 340B discounts.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: Lower Drug Costs for Families Act
This bill could make drug companies owe larger Medicare rebates when their prices rise faster than inflation. It counts more drug sales in the formula and measures price growth from 2016 instead of 2021. The bill starts the new Part D rules in late 2025 and the new Part B rules in 2026.
Use this page to support, oppose, or ask Congress to amend H.R.2554. Modern Action explains Lower Drug Costs for Families Act in plain English, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in Energy and Commerce
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
Latest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (4/1/2025)
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Lower Drug Costs for Families Act, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it would do, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around H.R.2554, your stance, and the reasons you choose, then lets you edit and send when ready.
